[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Live Attenuated Vaccine Market Report 2017

December 2017 | 95 pages | ID: UF6BA7AB121EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Live Attenuated Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Live Attenuated Vaccine in these regions, from 2012 to 2022 (forecast).
United States Live Attenuated Vaccine market competition by top manufacturers/players, with Live Attenuated Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Astellas Pharma (Japan)
  • CSL Limited (Australia)
  • Emergent BioSolutions (U.S.)
  • GlaxoSmithKline (U.K.)
  • Johnson & Johnson (U.S.)
  • MedImmune (U.S.)
  • Merck & Co (U.S.)
  • Pfizer (U.S.)
  • Sanofi Pasteur (France)
  • Serum Institute of India Pvt (India)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By End User
    • Pediatrics
    • Adults
  • By Disease Indication
    • Pneumococcal
    • Influenza
    • HPV
    • Hepatitis
    • Rotavirus
    • DTP
    • Polio
    • MMR
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Medical Center
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Live Attenuated Vaccine Market Report 2017

1 LIVE ATTENUATED VACCINE OVERVIEW

1.1 Product Overview and Scope of Live Attenuated Vaccine
1.2 Classification of Live Attenuated Vaccine by Product Category
  1.2.1 United States Live Attenuated Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Live Attenuated Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Pediatrics
  1.2.4 Adults
1.3 United States Live Attenuated Vaccine Market by Application/End Users
  1.3.1 United States Live Attenuated Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
  1.3.4 Others
1.4 United States Live Attenuated Vaccine Market by Region
  1.4.1 United States Live Attenuated Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Live Attenuated Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Live Attenuated Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Live Attenuated Vaccine (2012-2022)
  1.5.1 United States Live Attenuated Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Live Attenuated Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES LIVE ATTENUATED VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Live Attenuated Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Live Attenuated Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Live Attenuated Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Live Attenuated Vaccine Market Competitive Situation and Trends
  2.4.1 United States Live Attenuated Vaccine Market Concentration Rate
  2.4.2 United States Live Attenuated Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Live Attenuated Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LIVE ATTENUATED VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Live Attenuated Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Live Attenuated Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Live Attenuated Vaccine Price by Region (2012-2017)

4 UNITED STATES LIVE ATTENUATED VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Live Attenuated Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Live Attenuated Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Live Attenuated Vaccine Price by Type (2012-2017)
4.4 United States Live Attenuated Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LIVE ATTENUATED VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Live Attenuated Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Live Attenuated Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LIVE ATTENUATED VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Astellas Pharma (Japan)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Pharma (Japan) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 CSL Limited (Australia)
  6.2.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 CSL Limited (Australia) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Emergent BioSolutions (U.S.)
  6.3.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline (U.K.)
  6.4.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Johnson & Johnson (U.S.)
  6.5.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 MedImmune (U.S.)
  6.6.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 MedImmune (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Merck & Co (U.S.)
  6.7.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck & Co (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Pfizer (U.S.)
  6.8.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Pfizer (U.S.) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sanofi Pasteur (France)
  6.9.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sanofi Pasteur (France) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Serum Institute of India Pvt (India)
  6.10.2 Live Attenuated Vaccine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 LIVE ATTENUATED VACCINE MANUFACTURING COST ANALYSIS

7.1 Live Attenuated Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Live Attenuated Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Live Attenuated Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Live Attenuated Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LIVE ATTENUATED VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Live Attenuated Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Live Attenuated Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Live Attenuated Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Live Attenuated Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Live Attenuated Vaccine
Figure United States Live Attenuated Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Live Attenuated Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Pediatrics Product Picture
Figure Adults Product Picture
Figure United States Live Attenuated Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Live Attenuated Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Live Attenuated Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Live Attenuated Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Live Attenuated Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Live Attenuated Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Live Attenuated Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Live Attenuated Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Live Attenuated Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Live Attenuated Vaccine Sales Share by Players/Suppliers
Figure United States Live Attenuated Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Live Attenuated Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Live Attenuated Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Live Attenuated Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Live Attenuated Vaccine Revenue Share by Players/Suppliers
Table United States Market Live Attenuated Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Live Attenuated Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Live Attenuated Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Live Attenuated Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Live Attenuated Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Live Attenuated Vaccine Product Category
Table United States Live Attenuated Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Live Attenuated Vaccine Sales Share by Region (2012-2017)
Figure United States Live Attenuated Vaccine Sales Share by Region (2012-2017)
Figure United States Live Attenuated Vaccine Sales Market Share by Region in 2016
Table United States Live Attenuated Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Live Attenuated Vaccine Revenue Share by Region (2012-2017)
Figure United States Live Attenuated Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Live Attenuated Vaccine Revenue Market Share by Region in 2016
Table United States Live Attenuated Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Live Attenuated Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Live Attenuated Vaccine Sales Share by Type (2012-2017)
Figure United States Live Attenuated Vaccine Sales Share by Type (2012-2017)
Figure United States Live Attenuated Vaccine Sales Market Share by Type in 2016
Table United States Live Attenuated Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Live Attenuated Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by Type (2012-2017)
Figure Revenue Market Share of Live Attenuated Vaccine by Type in 2016
Table United States Live Attenuated Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Live Attenuated Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Live Attenuated Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Live Attenuated Vaccine Sales Market Share by Application (2012-2017)
Figure United States Live Attenuated Vaccine Sales Market Share by Application (2012-2017)
Figure United States Live Attenuated Vaccine Sales Market Share by Application in 2016
Table United States Live Attenuated Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Live Attenuated Vaccine Sales Growth Rate by Application (2012-2017)
Table Astellas Pharma (Japan) Basic Information List
Table Astellas Pharma (Japan) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure Astellas Pharma (Japan) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table CSL Limited (Australia) Basic Information List
Table CSL Limited (Australia) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure CSL Limited (Australia) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table Emergent BioSolutions (U.S.) Basic Information List
Table Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure Emergent BioSolutions (U.S.) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline (U.K.) Basic Information List
Table GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline (U.K.) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson (U.S.) Basic Information List
Table Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson (U.S.) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table MedImmune (U.S.) Basic Information List
Table MedImmune (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure MedImmune (U.S.) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table Merck & Co (U.S.) Basic Information List
Table Merck & Co (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure Merck & Co (U.S.) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table Pfizer (U.S.) Basic Information List
Table Pfizer (U.S.) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure Pfizer (U.S.) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur (France) Basic Information List
Table Sanofi Pasteur (France) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur (France) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table Serum Institute of India Pvt (India) Basic Information List
Table Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Growth Rate (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Sales Market Share in United States (2012-2017)
Figure Serum Institute of India Pvt (India) Live Attenuated Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Live Attenuated Vaccine
Figure Manufacturing Process Analysis of Live Attenuated Vaccine
Figure Live Attenuated Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Live Attenuated Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Live Attenuated Vaccine
Table Distributors/Traders List
Figure United States Live Attenuated Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Live Attenuated Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Live Attenuated Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Live Attenuated Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Live Attenuated Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Live Attenuated Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Live Attenuated Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Live Attenuated Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Live Attenuated Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Live Attenuated Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Live Attenuated Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Live Attenuated Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Live Attenuated Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories